BTIS
CLB icon

BB&T Investment Services’s Core Laboratories CLB Stock Holding History

BB&T Investment Services’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$105K Buy
987
+418
+73% +$41.7K 0.02% 392
2017
Q3 		$58K Buy
569
+351
+161% +$34K 0.01% 491
2017
Q2 		$22K Buy
218
+192
+738% +$20.7K 0.01% 643
2017
Q1 		$3K Buy
+26
New +$3.02K ﹤0.01% 880

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BB&T Investment Services's CLB Position: Q4 2017 in Review

BB&T Investment Services increased its Core Laboratories (CLB) stake by 73% in Q4 2017, buying an estimated $41.7K and bringing the position to 987 shares worth $105K. The position accounts for 0.02% of the portfolio, ranked #392.

BB&T Investment Services first reported a position in CLB in Q1 2017 and has held it in 4 quarters since. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • BB&T Investment Services held 987 shares of Core Laboratories worth $105K as of Q4 2017.
  • BB&T Investment Services bought 418 Core Laboratories shares in Q4 2017, an estimated $41.7K.
  • Core Laboratories made up 0.02% of BB&T Investment Services's portfolio in Q4 2017, its #392 holding.
  • BB&T Investment Services first reported a position in Core Laboratories in Q1 2017 and has held it in 4 quarters since.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.